Navigating these medications can feel complex
GLP-1 MODULATES LIPID METABOLISM GLP-1 Modulates fat synthesis in the liver GLP-1 modulates hepatic lipolysis GLP-1 modulates liver cholesterol metabolism GLP-1 modulates adiposynthetic and differentiation GLP-1 modulates fat browning Clinical application of GLP-1 in obesity Obesity is a major health problem worldwide
Not manufacturer COAs from six months ago
Contact your medical provider if you experience: Vomiting or diarrhea that does not improve Dizziness, fainting, or feeling like you may pass out Very little urination Confusion or extreme weakness Inability to keep fluids down Severe or worsening abdominal pain Signs of dehydration that do not improve with fluids Symptoms that become worse after a dose increase You should also reach out if you are unsure whether your symptoms are related to your medication, summer heat, dehydration, or another health concern
For commercial insurance patients, see our guide on what to do when insurance denies your Wegovy or Zepbound prescription, which covers documentation strategies, appeals, and cash-pay alternatives
The titration schedule from the clinical trial: **Weeks 1-4: 1mg** -- Adaptation phase